Effect of pre-germinated brown rice intake on diabetic neuropathy in streptozotocin-induced diabetic rats

Nutrition and Metabolism

Volumn 4, Issue , 2007, Pages

  Usuki, Seigo ^a   Ito, Yukihiko ^b   Morikawa, Keiko ^b   Kise, Mitsuo ^b   Ariga, Toshio ^a   Rivner, Michael ^a   Yu, Robert K ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Central Research Development Laboratory Fancl Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); GLUCOSE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; LIPID; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIET THERAPY; ENZYME ACTIVITY; ENZYME INHIBITION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; INCUBATION TIME; LIPID ANALYSIS; MALE; MOTOR NERVE CONDUCTION; NERVE MEMBRANE; NONHUMAN; RAT; RICE; RICE BRAN; SCIATIC NERVE;

RATTUS;

EID: 39549122594     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-4-25     Document Type: Article

References (45)

1. Pre-germinated brown rice. FANCL, Patent 2005 No. 3738025, JP Nov 4
2. The effect of pre-germinated brown rice intake on blood glucose and PAI-1 levels in streptozotocin-induced diabetic rats. H Hagiwara T Seki T Ariga, Biosci Biotechnol Biochem 2004 68 444 447 10.1271/bbb.68.444 14981313
3. Postprandial blood glucose and insulin responses to pre-germinated brown rice in healthy subjects. Y Ito A Mizukuchi M Kise H Aoto S Yamamoto R Yoshihara J Yokoyama, J Med Invest 2005 52 159 164 10.2152/jmi.52.159 16167533
4. Effect of pre-germinated brown rice on postprandial blood glucose and insulin level in subjects with hyperglycemia. Y Ito M Shen M Kise K Hayamizu G Yoshino R Yoshihara J Yokoyama, Jpn J Food Chem 2005 12 80 84
5. Insoluble fiber is a major constituent responsible for lowering the post-prandial blood glucose concentration in the pre-germinated brown rice. T Seiki R Nagase M Torimitsu M Yanagi Y Ito M Kise A Mizukuchi N Fujimura K Hayamizu T Ariga, Biol Pharm Bull 2005 28 1539 1541 10.1248/bpb.28.1539 16079511
6. Distribution of free amino acids in the rice kernel and kernel fractions and the effect of water soaking on the distribution. T Saikusa T Horino Y Mori, J Agri Food Chem 1994 42 1122 1125 10.1021/jf00041a015
7. Stimulation of gamma-aminobutyric acid synthesis activity in brown rice by a chitosan/glutamic acid germination solution and calcium/calmodulin. SH Oh, J Biochem Mol Biol 2003 36 319 325 12787489
8. Diabetic neuropathy: a continuing enigma. K Y Sugimoto Sima AA Murakawa, Diabetes Metab Res Rev 2000 16 408 433 10.1002/1520-7560(200011/12)16:6<408:: AID-DMRR158>3.0.CO;2-R 11114101
9. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. PJ Dyck BR Zimmerman TH Vilen SR Minnerath JL Karnes JK Yao JF Poduslo, N Engl J Med 1988 319 542 548 3136330
10. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. GJ Biessels NA Cristino GJ Rutten FP Hamers DW Erkelens WH Gispen, Brain 1999 122 757 768 10.1093/brain/122.4.757 10219786
11. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: A multimodal analysis. E Leonelli R Bianchi G Cavaletti D Caruso D Crippa LM Garcia-Segura G Lauria V Magnaghi I Roglio RC Melcangi, Neuroscience 2007 144 1293 1304 10.1016/j.neuroscience.2006.11.014 17187935
12. Oxidative stress in the pathogenesis of diabetic neuropathy. AM Vincent JW Russell P Low EL Feldman, Endocr Rev 2004 25 612 628 10.1210/er.2003-0019 15294884
13. EURODIAB Prospective Complications Study Group: Vascular risk factors and diabetic neuropathy. S Tesfaye N Chaturvedi SE Eaton JD Ward C Manes C Ionescu-Tirgoviste DR Witte JH Fuller, N Engl J Med 2005 352 341 350 10.1056/NEJMoa032782 15673800
14. +-ATPase activity induced by homocysteine is probably mediated by oxidative stress. EL Streck AI Zugno B Tagriari R Franzon CM Wannmacher M Wajner AT Wyse, Neurochem Res 2001 26 1195 1200 10.1023/A:1013907104585 11874200
15. +-ATPase activity caused by homocysteine. EL Streck AI Zugno B Tagliari JJ Sarkis M Wajner CM Wannmacher AT Wyse, Int J Dev Neuroscience 2002 20 77 81 10.1016/S0736-5748(02)00043-6
16. Modification induced by homocysteine and low-density lipoprotein on human aortic endothelial cells: An in vitro study. A Vignini L Nanette T Bacchante G Ferrety G Curtail L Mezzanine, J Clin Endocrinol Metab 2004 89 4558 4561 10.1210/jc.2004-0419 15356062
17. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. DI Draganov JF Teiber A Speelman Y Osawa R Sunahara BN La Du, J Lipid Res 2005 46 1239 1247 10.1194/jlr.M400511-JLR200 15772423
18. "A" esterase and their role in regulating the toxicity of organophosphates. CH Walker MI Mackness, Arch Toxicol 1987 60 30 33 10.1007/BF00296942 3304214
19. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. MI Mackness D Harty D Bhatnagar PH Winocour S Arrol M Ishola PN Durrington, Atherosclerosis 1991 86 193 199 10.1016/0021-9150(91)90215-O 1651732
20. Serum esterase activities and hyperlipidaemia in the streptozotocin- diabetic rat. BN Patel MI Mackness DW Harty S Arrol RP Boot-Handford PN Durrington, Biochim Biophys Acta 1990 1035 113 116 2143419
21. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. CA Abbott MI Mackness S Kumar AJ Boulton PN Durrington, Arterioscler Theromb Vascbiol 1995 15 11 1812 1818
22. Effect of homocysteinylation on human high-density lipoproteins: Correlation with paraoxonase activity. G Ferretti T Bacchetti E Marotti G Curatola, Metabolism 2003 52 146 151 10.1053/meta.2003.50033 12601623
23. Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay. T Kosaka M Yamaguchi T Motomura K Mizuno, Clinica Chimica Acta 2005 359 156 162 10.1016/j.cccn.2005.03.046
24. Inability of insulin to maintain normal nerve function during high-frequency stimulation in diabetic rat-tail nerves. H Andersen JF Nielsen VK Nielsen, Muscle & Nerve 1994 17 80 84 10.1002/mus.880170111 8264706
25. Molecular mimicry: Sensitization of Lewis rats with Campylobacter jejuni lipopolysaccharides induces formation of antibody toward GD3 ganglioside. S Usuki SA Thompson MH Rivner K Taguchi K Shibata T Ariga RK Yu, J Neurosci Res 2006 83 274 284 10.1002/jnr.20717 16342208
26. A simple method for the isolation and purification of total lipids from animal tissues. J Folch M Lees GH Sloane Stanley, J Biol Chem 1957 226 497 509 13428781
27. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. BH Chung T Wilkinson JC Geer JP Segrest, J Lipid Res 1980 21 284 291 7381323
28. +)ATPase activity is reversed by cAMP. IV Silva C Caruso-Neves IM Azeredo TLG Carvalho LS Lara MC de Mello AG Lopes, Arch Biochem Biophys 2002 406 183 189 10.1016/S0003-9861(02) 00405-8 12361706
29. Toxicity of erythrophleum guineense stem-bark: role of alkaloidal fraction. BA Adeoye OO Oyedapo, Afr J Trad CAM 2004 1 45 54
30. Pancreatic beta cell toxicity by streptozotocin anomers. AA Rossini AA Like WE Dulin GF Cahill Jr, Diabetes 1977 26 1120 1124 10.2337/diabetes.26.12. 1120 145386
31. Increased norepinephrine content in diabetic rat heart. H Fushimi T Inoue H Namikawa B Kishino M Nishikawa Y Tochino S Funakawa, J Biochem 1982 91 1805 1807 7096317
32. Tissue noradrenaline and the polyol pathway in experimentally diabetic rats. PD Lucas A Qirbi, Br J Pharmacol 1989 97 347 352 2503223
33. Biomedicine. A sympathetic defense against obesity. AG Dulloo, Science 2002 297 780 781 10.1126/science.1074923 12161638
34. Peripheral nerve pathology in rats with streptozotocin-induced insulinoma. K Sugimoto S Yagihashi, Acta Neuropathol 1996 91 616 623 10.1007/s004010050475 8781661
35. Streptozotocin induced diabetes as a model of phrenic nerve neuropathy in rats. OA Rodrigues Filho VP Fazan, J Neurosci Meth 2006 151 131 138 10.1016/j.jneumeth.2005.06.024
36. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus. NA Abdella OA Mojiminiyi AO Akanji MA Moussa, Acta Diabetol 2002 39 183 190 10.1007/s005920200033 12486492
37. Pathophysiological consequences of homocysteine excess. H Jakubowski, J Nutr 2006 136 1741S 1749S 16702349
38. A study of the relationship between homocysteine and diabetic nephropathy in rats. Y Unlucerci S Bekpinar F Gurdol G Seferoglu, Pharmacol Res 2002 45 249 252 10.1006/phrs.2001.0942 11884223
39. Insulin increases homocysteine levels in a dose-dependent manner in diabetic rats. MF Gursu G Baydas G Cikim H Canatan, Arch Med Res 2002 33 305 307 10.1016/S0188-4409(01)00379-4 12031639
40. Effect of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. RL Jacobs JD House ME Brosnan JT Brosnan, Diabetes 1998 47 1967 1970 10.2337/diabetes.47.12.1967 9836532
41. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus. D Juretic A Motejlkova B Kunovic B Rekic Z Flegar-Mestric L Vujic R Mesic J Lukac-Bajalo V Simeon-Rudolf, Acta Pharm 2006 56 59 68 16613735
42. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus. MR Lakshman CS Gottipati SJ Narasimhan J Munoz P Marmillot ES Nylen, Metabolism 2006 55 1201 1206 10.1016/j.metabol.2006.06.001 16919539
43. Plasma markers of endothelial dysfunction in type 2 diabetics. E Moldoveanu C Tanaseanu S Tanaseanu T Kosaka G Manea DS Marta LM Popescu, Eur J Intern Med 2006 17 38 42 10.1016/j.ejim.2005.09.015 16378884
44. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. ST Reddy DJ Wadleigh V Grijalva C Ng S Hama A Gangopadhyay DM Shih AJ Lusis M Navab AM Fogelman, Arterioscler Thromb Vasc Biol 2001 21 542 547 11304470
45. Identification of paraoxonase 3 in rat liver microsomes: purification and biological properties. L Rodrigo F Gil AF Hernandez O Lopez A Pla, Biochem J 2003 376 261 268 12946270 10.1042/BJ20030732